SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-07-013492
Filing Date
2007-03-19
Accepted
2007-03-19 16:55:15
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 v068807_10k.htm 10-K 3024143
2 GRAPHIC totalshareholder.jpg GRAPHIC 31611
3 v068807_ex21.htm EX-21 15909
4 v068807_ex23-1.htm EX-23.1 4472
5 v068807_ex23-2.htm EX-23.2 4151
6 v068807_ex31-1.htm EX-31.1 16904
7 v068807_ex31-2.htm EX-31.2 15000
8 v068807_ex32-1.htm EX-32.1 6358
9 v068807_ex32-2.htm EX-32.2 6820
  Complete submission text file 0001144204-07-013492.txt   3138925
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13441 | Film No.: 07703934
SIC: 2836 Biological Products, (No Diagnostic Substances)